APGE
Price
$53.55
Change
+$1.18 (+2.25%)
Updated
Oct 15, 11:14 AM (EDT)
Capitalization
3.65B
33 days until earnings call
Intraday Buy/Sell Signals
PROK
Price
$3.17
Change
+$0.08 (+2.59%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
417.13M
33 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

APGE vs PROK

Header iconAPGE vs PROK Comparison
Open Charts APGE vs PROKBanner chart's image
Apogee Therapeutics
Price$53.55
Change+$1.18 (+2.25%)
Volume$300
Capitalization3.65B
ProKidney
Price$3.17
Change+$0.08 (+2.59%)
Volume$900
Capitalization417.13M
APGE vs PROK Comparison Chart in %
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. PROK commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (APGE: $52.37 vs. PROK: $3.09)
Brand notoriety: APGE and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 131% vs. PROK: 69%
Market capitalization -- APGE: $3.65B vs. PROK: $417.13M
APGE [@Biotechnology] is valued at $3.65B. PROK’s [@Biotechnology] market capitalization is $417.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 6 TA indicator(s) are bullish while PROK’s TA Score has 6 bullish TA indicator(s).

  • APGE’s TA Score: 6 bullish, 4 bearish.
  • PROK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both APGE and PROK are a good buy in the short-term.

Price Growth

APGE (@Biotechnology) experienced а +31.81% price change this week, while PROK (@Biotechnology) price change was +4.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

APGE is expected to report earnings on Nov 18, 2025.

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($3.65B) has a higher market cap than PROK($417M). PROK YTD gains are higher at: 82.840 vs. APGE (15.607). PROK has higher annual earnings (EBITDA): -157.52M vs. APGE (-270.1M). APGE has more cash in the bank: 505M vs. PROK (295M). PROK has less debt than APGE: PROK (4.42M) vs APGE (10.8M). PROK has higher revenues than APGE: PROK (527K) vs APGE (0).
APGEPROKAPGE / PROK
Capitalization3.65B417M876%
EBITDA-270.1M-157.52M171%
Gain YTD15.60782.84019%
P/E RatioN/AN/A-
Revenue0527K-
Total Cash505M295M171%
Total Debt10.8M4.42M244%
TECHNICAL ANALYSIS
Technical Analysis
APGEPROK
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
72%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
67%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 8 days ago
74%
Declines
ODDS (%)
Bearish Trend 10 days ago
72%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
68%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FOCPX23.98N/A
N/A
Fidelity OTC
HNCSX21.91N/A
N/A
Hartford International Growth R4
AFDAX57.22N/A
N/A
American Century Large Cap Equity A
FCMVX12.28N/A
N/A
Fidelity Mid Cap Value K6
JAWGX77.81-0.04
-0.05%
Janus Henderson VIT Global Rsrch Instl

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-2.96%
SYRE - APGE
59%
Loosely correlated
+11.02%
CGON - APGE
52%
Loosely correlated
-0.23%
NUVL - APGE
50%
Loosely correlated
-5.66%
IRON - APGE
50%
Loosely correlated
+1.45%
DYN - APGE
50%
Loosely correlated
+10.26%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RLYB. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RLYB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+3.34%
RLYB - PROK
44%
Loosely correlated
+1.27%
NRIX - PROK
39%
Loosely correlated
-5.61%
APGE - PROK
38%
Loosely correlated
-2.96%
KYMR - PROK
37%
Loosely correlated
-2.87%
ZYME - PROK
37%
Loosely correlated
+0.66%
More